Isabelle Riviere
Vice President, Cell Therapy Sciences Takeda
Seminars
Wednesday 16th September 2026
Scaling to Phase 1 – A Biotech & Cancer Center Perspective
12:10 pm
- Designing small-scale, cost-effective strategies to effectively scale therapies
- Highlighting technologies to secure a highquality scale to phase 1 clinical trials
